![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Dr. Reddy\'s Laboratories (2)
02 AstraZeneca (27)
03 Olon S.p.A (2)
04 TherDose Pharma (2)
05 XYZ Pharma (1)
01 CAPSULE;ORAL (1)
02 Capsule (1)
03 Capsule, hard (1)
04 Film Coated Tablet (2)
05 HARD CAPSULES (1)
06 Liquid-filled capsules (1)
07 Olaparib 50Mg 448 Unita' Oral Use (1)
08 Oral Solid Dosage Form (2)
09 TAB (2)
10 TABLET (2)
11 TABLET;ORAL (2)
12 Tablets (2)
13 Blank (16)
01 Available Dossier- US-EU-RoW (1)
02 DISCN (1)
03 Lead Market Dossiers- Under Development (2)
04 Originator (2)
05 Prescription (2)
06 RX (2)
07 Blank (24)
01 LYNPARZA (5)
02 Lynparza (21)
03 Blank (8)
01 Argentina (1)
02 Australia (16)
03 Canada (2)
04 India (4)
05 Italy (3)
06 Norway (1)
07 South Africa (2)
08 Sweden (1)
09 Switzerland (1)
10 USA (3)